AstraZeneca said on Friday it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients at a discount of up to 70% off list prices, the latest pharma company to do so after pressure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback